NeoImmuneTech Revenue

Biotechnology Research • Rockville, Maryland, United States • 21-50 Employees

NeoImmuneTech revenue & valuation

Annual revenue	$3,500,000
Revenue per employee	$88,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,200,000
Total funding	No funding

Key Contacts at NeoImmuneTech

Luke Oh

Chief Executive Officer

Alex Yongho

Senior Director, Head Of Clinical Operations Division

Daniel Rho

Senior Director Business Development

지영 주

Executive Director

Lucy Lim

Senior Director

희영 정

Senior Director Of Cmc Qa

Hye Jeong

Medical Director Of Drug Safety And Pharmacovigilance

Hyun Jee Kim

Director Of Strategy & Planning

Jiyoung J

Executive Director

Company overview

Headquarters	2400 Research Blvd., Suite 250, Rockville, MD 20850, US
Phone number	+12408019068
Website	neoimmunetech.com
NAICS	541714
SIC	873
Founded	2014
Employees	21-50
Socials

NeoImmuneTech Email Formats

NeoImmuneTech uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@neoimmunetech.com), used 91.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@neoimmunetech.com	91.7%
{first name}{last name}	johndoe@neoimmunetech.com	8.3%

About NeoImmuneTech

NeoImmuneTech, Inc. (NIT) is a clinical-stage T cell-focused biopharmaceutical company dedicated to expanding the horizon of immuno-oncology and enhancing immunity to infectious diseases. Our lead drug candidate, NT-I7, is the only clinical-stage long acting rhIL-7, and is uniquely positioned to address unmet medical needs in Immuno-Oncology and Infectious Diseases. IL-7 is a fundamental cytokine for lymphocyte development, survival, and memory development. Furthermore, NT-I7 has been shown clinically to have desired PK/PD and safety profiles, making it an ideal combination partner with T-cell targeted therapies. NT-I7 is being studied in multiple clinical trials and many in collaboration with industry leaders in I-O, including Merck and Roche for CPI combination trials. Follow us on X @neoimmunetech

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Director

Employees by Department

NeoImmuneTech has 19 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore NeoImmuneTech's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2018-02-01	1	N/A

Funding Insights

Number of funding rounds

NeoImmuneTech Tech Stack

Discover the technologies and tools that power NeoImmuneTech's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Tailwind CSS

UI frameworks

Google Maps

Maps

Microsoft 365

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

PHP

Programming languages

Bootstrap

UI frameworks

Emotion

Development

Amazon Web Services

PaaS

Next.js

JavaScript frameworks

GoDaddy

Hosting

Frequently asked questions

NeoImmuneTech is located in Rockville, Maryland, US.

You can reach NeoImmuneTech at +12408019068.

NeoImmuneTech generates an estimated annual revenue of $3,500,000. This revenue figure reflects the company's market position and business performance in its industry.

NeoImmuneTech has an estimated valuation of $11,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NeoImmuneTech was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

NeoImmuneTech has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at NeoImmuneTech

Luke Oh

Chief Executive Officer

Alex Yongho

Senior Director, Head Of Clinical Operations Division

Daniel Rho

Senior Director Business Development

지영 주

Executive Director

Lucy Lim

Senior Director